ADMA Financials

Adma Biologics Inc - Financial statements & key metrics

Stock Price

$17.59

Market Cap

$4.20B

P/E Ratio

20.5

EPS

$0.86

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$426.45M

Gross Profit

Operating Income

Net Income

$197.67M

EPS (Diluted)

$0.81

Balance Sheet Highlights

Total Assets

$488.68M

Total Liabilities

$139.66M

Shareholders Equity

Cash & Equivalents

$103.15M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$118.67M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

54.7%

Operating Margin

0.4%

Net Margin

0.4%

ROE

0.6%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is ADMA revenue?

ADMA's most recent quarterly revenue was $426.45M. Annual revenue can be calculated by summing the four most recent quarters.

Is ADMA profitable?

ADMA reported a profit of $197.67M in the most recent quarter. The net profit margin is 0.4%.

What is ADMA market cap?

ADMA has a market capitalization of $4.20B, making it a mid-cap stock.

Does ADMA have debt?

View ADMA's balance sheet for debt information.

What is ADMA cash flow?

Cash flow data is available in the full financial statements.